Incyte Balance Sheet
NASDAQ: INCYHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Incyte financial position
At the end of fiscal 2025, Incyte reported total assets of $6.96 billion, up 27.8% from a year earlier against total liabilities of $1.79 billion. Shareholders' equity stood at $5.17 billion, or 74.3% of assets. The company held $3.10 billion in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 3.32, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Incyte balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.10B | 1.69B | 3.21B | 2.95B | 2.06B | 1.51B | 1.83B | 1.16B | 899.51M | 652.34M |
| Short-Term Investments | — | — | 442.67M | 287.54M | 290.75M | 288.37M | 284.87M | 274.34M | 270.14M | 156.20M |
| Inventory | 101.06M | 58.87M | 62.97M | 41.99M | 27.90M | 16.43M | 11.40M | 6.97M | 6.48M | 4.11M |
| Total Current Assets | 5.02B | 3.24B | 4.65B | 4.09B | 3.12B | 2.36B | 2.48B | 1.83B | 1.50B | 994.18M |
| Property, Plant & Equipment | 730.88M | 763.41M | 751.51M | 739.31M | 723.92M | 559.63M | 377.57M | 319.75M | 259.76M | 167.68M |
| Goodwill | 133.00M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M |
| Intangible Assets | — | — | — | — | — | — | — | — | 236.90M | 270.44M |
| Long-Term Investments | — | — | 187.72M | 133.68M | 221.27M | 222.30M | 133.66M | 99.20M | 134.36M | 31.99M |
| Total Assets | 6.96B | 5.44B | 6.78B | 5.84B | 4.93B | 3.56B | 3.43B | 2.65B | 2.30B | 1.64B |
| Accounts Payable | 209.94M | 197.47M | 109.60M | 277.55M | 172.11M | 98.77M | 83.65M | 103.83M | 67.67M | 75.60M |
| Total Current Liabilities | 1.52B | 1.64B | 1.24B | 1.16B | 854.31M | 631.20M | 513.34M | 425.28M | 375.40M | 273.50M |
| Long-Term Debt | — | — | — | — | — | — | — | 19.09B | 26.80M | 749.80M |
| Total Liabilities | 1.79B | 2.00B | 1.59B | 1.47B | 1.16B | 949.65M | 828.34M | 719.79M | 671.95M | 1.22B |
| Shareholders' Equity | 5.17B | 3.45B | 5.19B | 4.37B | 3.77B | 2.61B | 2.60B | 1.93B | 1.63B | 419.47M |
| Retained Earnings | 213.77M | -1.07B | 160.38M | -437.21M | -777.87M | -1.73B | -1.43B | -1.88B | -1.99B | -1.67B |
| Total Debt | — | — | — | — | — | — | — | 19.09B | 26.80M | 749.80M |
| Net Cash (Debt) | 3.10B | 1.69B | 3.66B | 3.24B | 2.35B | 1.80B | 2.12B | -17.66B | 1.14B | 58.75M |
| Shares Outstanding | 198.46M | 193.43M | 224.29M | 222.75M | 221.08M | 219.49M | 216.18M | 213.27M | 211.26M | 188.85M |
This table shows 10 annual periods of Incyte's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow INCY's reporting calendar. What is a balance sheet?